LCA5L anticorps
Aperçu rapide pour LCA5L anticorps (ABIN630546)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Affinity purified
-
Immunogène
- C21 ORF13 antibody was raised using a synthetic peptide corresponding to a region with amino acids GSEEPLQSKESHPLPPSQASTSHAFGDSKVTVVNSIKPSSPTEGKRKIII
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
C21ORF13 Blocking Peptide, (ABIN938942), is also available for use as a blocking control in assays to test for specificity of this C21ORF13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C20 RF13 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
-
Autre désignation
- C21ORF13
-
Sujet
- The function of the C21orf13 protein has not been widely studied, and is yet to be fully elucidated.
-
Poids moléculaire
- 76 kDa (MW of target protein)
Antigène
-